ART is so effective that most people in the U.S. with HIV who get ART will never develop AIDS. That’s why ART is so important. Without it, your HIV levels will grow and your CD4 levels will fall.

Unlike progressors, people who experience the expected progression of HIV to AIDS, VNPs exhibit relatively stable CD4 + T ...

The rate of fatal non–AIDS-defining cancers was 10 times lower in patients with CD4 counts >500 cells/mm 3 than in those with CD4 counts <50 cells/mm 3. Evidence is accumulating to indicate that ...

If your virus is not controlled and you have a low CD4 count (AIDS), they will want to do tests for various opportunistic infections. Your doctor will also ask you questions about weight loss and ...

On left, the HIV virus binds to CD4 T cell CD4 receptor ... The death sentence of AIDS has been significantly decreased across the world in the last 20 years, since The U.S. President’s ...

CD4 and viral load test results give essential information about ... We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital in ...

HIV therapy protects the immune system by controlling the virus and preventing disease progression. This article takes a ...

People with a CD4 count below 200 are considered to have AIDS and are more susceptible to opportunistic infections. In general, higher CD4 counts offer better protection and hint at a more robust ...

HIV and AIDS are not the same thing. HIV is a virus that attacks the body’s immune system, specifically white blood cells called CD4 T cells, which help the body fight infections. They are also ...

HIV is an infection that attacks cells in your immune system, known as CD4 cells. If untreated, HIV may progress to acquired immunodeficiency syndrome (AIDS), which increases the risk of severe ...

In a large cohort, viral loads of 400-20,000 copies/mL conferred a similar risk for AIDS or death as viral loads ... patients in this analysis had lower CD4-cell counts and higher viral loads ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, will ...